Skip to content

Timken TKR Receivables

Receivables at other companies

Idexx Laboratories logo
Idexx LaboratoriesIDXX
$20.6M+7.3%
Chart Industries logo
Chart IndustriesGTLS
$1.05B+25.4%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$1.16B+24.5%
Evercore logo
EvercoreEVR
$546.57M+16.5%
Vistra logo
VistraVST
$750M-30.7%
Accenture logo
AccentureACN
$16.04B+6.2%

Other financials

Income statement

See full
Revenue$1.2B+8.0%
Gross profit$394.0M+9.8%
Operating income$168.6M+17.1%
Net income$98.2M+25.4%
EPS (diluted)$1.40+26.1%

Balance sheet

See full
Cash & equivalents$344.7M-8.3%
Total debt$2.2B-2.1%
Total equity$3.2B+9.9%
Total assets$6.9B+4.7%

Cash flow

See full
Operating cash flow$39.3M-32.9%
CapEx$38.8M+10.2%
Free cash flow$500.0K-97.9%

Valuation

See full
Market cap$9.89B+39.1%
Enterprise value$11.74B+28.3%
P/E32.1×+10.4×
P/S2.1×+0.5×

Profitability

See full
Gross margin30.6%-0.4pp
Operating margin12.1%-0.5pp
Net margin6.6%-0.6pp
FCF margin8.2%+1.0pp

Returns & leverage

See full
Return on equity10.1%-1.8pp
Debt / equity0.7×-0.1×
Current ratio2.9×-0.3×

Where this comes from

Reported directly by Timken in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerAssetReclassifiedToReceivable.

The official record: Timken’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Timken's receivables.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Timken's receivables?
Timken (TKR) reported receivables of $80.4M in Q1 2026.
How has Timken's receivables changed year-over-year?
Timken's receivables increased by 13.6% year-over-year, from $70.8M to $80.4M.
What is the long-term trend for Timken's receivables?
Over 2 years (2022 to 2025), Timken's receivables has grown at a -0.1% compound annual growth rate (CAGR), from $370.5M to $370.1M.